Oppenheimer & Co’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.95M | Buy |
12,795
+11,055
| +635% | +$4.1M | 0.05% | 364 |
|
|
2026
Q1 | $509K | Buy |
+1,740
| New | +$572K | 0.01% | 1185 |
|
|
2025
Q4 | – | Sell |
-2,478
| Closed | -$801K | – | 1630 |
|
|
2025
Q3 | $801K | Sell |
2,478
-3,044
| -55% | -$947K | 0.01% | 998 |
|
|
2025
Q2 | $2.15M | Sell |
5,522
-222
| -4% | -$89.3K | 0.03% | 552 |
|
|
2025
Q1 | $2.5M | Buy |
5,744
+123
| +2% | +$49.4K | 0.04% | 484 |
|
|
2024
Q4 | $2.07M | Buy |
5,621
+122
| +2% | +$51.1K | 0.03% | 539 |
|
|
2024
Q3 | $2.86M | Sell |
5,499
-68
| -1% | -$36.3K | 0.04% | 431 |
|
|
2024
Q2 | $3.02M | Sell |
5,567
-434
| -7% | -$229K | 0.05% | 401 |
|
|
2024
Q1 | $3.11M | Buy |
6,001
+285
| +5% | +$142K | 0.05% | 393 |
|
|
2023
Q4 | $2.7M | Sell |
5,716
-154
| -3% | -$71.2K | 0.05% | 418 |
|
|
2023
Q3 | $2.56M | Buy |
5,870
+360
| +7% | +$163K | 0.05% | 391 |
|
|
2023
Q2 | $2.45M | Sell |
5,510
-1,262
| -19% | -$582K | 0.05% | 419 |
|
|
2023
Q1 | $3.11M | Sell |
6,772
-1,095
| -14% | -$521K | 0.07% | 326 |
|
|
2022
Q4 | $4.04M | Sell |
7,867
-3,960
| -33% | -$2.01M | 0.09% | 265 |
|
|
2022
Q3 | $5.37M | Sell |
11,827
-5,246
| -31% | -$2.51M | 0.13% | 199 |
|
|
2022
Q2 | $8.24M | Sell |
17,073
-816
| -5% | -$404K | 0.18% | 123 |
|
|
2022
Q1 | $8.79M | Buy |
17,889
+64
| +0.4% | +$29.3K | 0.16% | 136 |
|
|
2021
Q4 | $8.26M | Sell |
17,825
-1,022
| -5% | -$430K | 0.14% | 148 |
|
|
2021
Q3 | $7.03M | Sell |
18,847
-16,233
| -46% | -$6.17M | 0.13% | 170 |
|
|
2021
Q2 | $13.4M | Buy |
35,080
+318
| +0.9% | +$122K | 0.24% | 92 |
|
|
2021
Q1 | $12.5M | Sell |
34,762
-130
| -0.4% | -$41.8K | 0.25% | 84 |
|
|
2020
Q4 | $11.2M | Buy |
34,892
+230
| +0.7% | +$70.6K | 0.24% | 93 |
|
|
2020
Q3 | $9.31M | Sell |
34,662
-1,963
| -5% | -$528K | 0.23% | 91 |
|
|
2020
Q2 | $9.63M | Buy |
36,625
+15,215
| +71% | +$4.06M | 0.25% | 85 |
|
|
2020
Q1 | $4.86M | Sell |
21,410
-541
| -2% | -$147K | 0.15% | 145 |
|
|
2019
Q4 | $6.63M | Sell |
21,951
-498
| -2% | -$137K | 0.16% | 135 |
|
|
2019
Q3 | $5.39M | Buy |
22,449
+4,227
| +23% | +$1.16M | 0.15% | 156 |
|
|
2019
Q2 | $5.14M | Buy |
18,222
+144
| +0.8% | +$39.3K | 0.14% | 167 |
|
|
2019
Q1 | $5.19M | Sell |
18,078
-1,311
| -7% | -$379K | 0.14% | 162 |
|
|
2018
Q4 | $5.09M | Sell |
19,389
-45
| -0.2% | -$12.4K | 0.16% | 138 |
|
|
2018
Q3 | $5.33M | Sell |
19,434
-550
| -3% | -$143K | 0.14% | 178 |
|
|
2018
Q2 | $4.76M | Sell |
19,984
-1,473
| -7% | -$341K | 0.13% | 178 |
|
|
2018
Q1 | $4.71M | Sell |
21,457
-2,270
| -10% | -$533K | 0.12% | 184 |
|
|
2017
Q4 | $5.34M | Sell |
23,727
-1,513
| -6% | -$322K | 0.14% | 175 |
|
|
2017
Q3 | $4.79M | Sell |
25,240
-22
| -0.1% | -$4.19K | 0.13% | 184 |
|
|
2017
Q2 | $4.75M | Sell |
25,262
-200
| -0.8% | -$35.9K | 0.13% | 185 |
|
|
2017
Q1 | $4.21M | Buy |
25,462
+64
| +0.3% | +$10.2K | 0.12% | 206 |
|
|
2016
Q4 | $3.65M | Sell |
25,398
-24,544
| -49% | -$3.29M | 0.11% | 225 |
|
|
2016
Q3 | $6.26M | Sell |
49,942
-1,985
| -4% | -$256K | 0.18% | 127 |
|
|
2016
Q2 | $6.82M | Buy |
51,927
+189
| +0.4% | +$25.9K | 0.2% | 108 |
|
|
2016
Q1 | $7.19M | Sell |
51,738
-6,708
| -11% | -$896K | 0.22% | 104 |
|
|
2015
Q4 | $8.15M | Sell |
58,446
-2,791
| -5% | -$384K | 0.24% | 97 |
|
|
2015
Q3 | $8.57M | Buy |
61,237
+13,486
| +28% | +$2.03M | 0.26% | 84 |
|
|
2015
Q2 | $7.84M | Buy |
47,751
+4,693
| +11% | +$750K | 0.22% | 104 |
|
|
2015
Q1 | $6.65M | Sell |
43,058
-2,262
| -5% | -$322K | 0.18% | 133 |
|
|
2014
Q4 | $5.7M | Sell |
45,320
-1,238
| -3% | -$153K | 0.16% | 151 |
|
|
2014
Q3 | $5.57M | Sell |
46,558
-4,733
| -9% | -$543K | 0.17% | 142 |
|
|
2014
Q2 | $5.52M | Sell |
51,291
-21,129
| -29% | -$2.18M | 0.17% | 140 |
|
|
2014
Q1 | $7.21M | Buy |
72,420
+29,153
| +67% | +$2.64M | 0.22% | 111 |
|
|
2013
Q4 | $4M | Sell |
43,267
-22,648
| -34% | -$2.01M | 0.13% | 197 |
|
|
2013
Q3 | $5.51M | Buy |
65,915
+35,995
| +120% | +$3.08M | 0.19% | 134 |
|
|
2013
Q2 | $2.45M | Buy |
+29,920
| New | +$2.24M | 0.09% | 260 |
|
Other funds holding ELV
Oppenheimer & Co's ELV Position: Q2 2026 in Review
Oppenheimer & Co increased its Elevance Health (ELV) stake by 635% in Q2 2026, buying an estimated $4.1M and bringing the position to 12,795 shares worth $4.95M. The position accounts for 0.05% of the portfolio, ranked #364.
Oppenheimer & Co first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $13.4M in Q2 2021. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Oppenheimer & Co held 12,795 shares of Elevance Health worth $4.95M as of Q2 2026.
- Oppenheimer & Co bought 11,055 Elevance Health shares in Q2 2026, an estimated $4.1M.
- Elevance Health made up 0.05% of Oppenheimer & Co's portfolio in Q2 2026, its #364 holding.
- Oppenheimer & Co first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- Oppenheimer & Co's Elevance Health position peaked at $13.4M in Q2 2021.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.